The Europe dietary supplements market size was estimated at USD 49.39 billion in 2025 and is projected to reach USD 97.76 billion by 2033, growing at a CAGR of 9.0% from 2026 to 2033. Growing technological innovation in the nutraceuticals sector offers new opportunities for the dietary supplements market in Europe.
The Federation of European Nutrition Societies (FENS) funds and invests in various nutritional food and nutricosmetic businesses. The federation operates and nurtures the growth of such companies in 26 countries in the region.
The European Society for Clinical Nutrition and Metabolism (ESPEN) governs and offers grants for businesses in the nutrition sector, and also honors the best-performing organizations in the industry. Such initiatives have encouraged participants to develop highly beneficial, innovative products, thereby boosting the growth of the European dietary supplements industry.
Probiotic food supplements continue to contribute significantly to the growth of the Europe food supplements market. Many medical professionals in Europe recommend probiotic supplements for their various health benefits, including increased immunity.
The prevalence of lactose intolerance and obesity in Europe has further increased the demand for probiotic health supplements. Probiotic supplements are increasingly consumed in the region by consumers with lactose intolerance, thereby contributing to the growth of the probiotics segment across other applications.
Across the European Union, a rapidly aging population is becoming a key structural driver of dietary supplement demand, as a growing proportion of consumers are over 60 and increasingly focused on maintaining mobility, immunity, and overall quality of life. Age-related physiological changes, along with behavioral and social factors, raise vulnerability to chronic conditions such as osteoporosis, cardiovascular diseases, joint problems, and cognitive decline, prompting greater reliance on preventive nutrition. As a result, supplements such as calcium, vitamin D, omega-3s, magnesium, and targeted formulations for heart, bone, and brain health are becoming part of daily health routines rather than occasional purchases.
This trend is clearly reflected in Germany, where around one in five adults is aged 65 or older, and the share of seniors is expected to keep rising. According to figures from the Max Rubner Institute National Nutrition Survey II and the KPRA Age Study, women aged 65-80 are the most active supplement users, with 54% of women and 34% of men in this age group regularly taking food supplements. Such high adoption among older adults highlights how demographic ageing directly expands the core consumer base and supports sustained, long-term growth in the European dietary supplements market.
In August 2025, IBSA Group launched orodispersible film food supplements containing iron, vitamin D3, and vitamin B12 using its patented FilmTec technology across new European markets, expanding its international presence with easy-to-take, precisely dosed formats.
This product will be delivered within 1-3 business days.
The Federation of European Nutrition Societies (FENS) funds and invests in various nutritional food and nutricosmetic businesses. The federation operates and nurtures the growth of such companies in 26 countries in the region.
The European Society for Clinical Nutrition and Metabolism (ESPEN) governs and offers grants for businesses in the nutrition sector, and also honors the best-performing organizations in the industry. Such initiatives have encouraged participants to develop highly beneficial, innovative products, thereby boosting the growth of the European dietary supplements industry.
Probiotic food supplements continue to contribute significantly to the growth of the Europe food supplements market. Many medical professionals in Europe recommend probiotic supplements for their various health benefits, including increased immunity.
The prevalence of lactose intolerance and obesity in Europe has further increased the demand for probiotic health supplements. Probiotic supplements are increasingly consumed in the region by consumers with lactose intolerance, thereby contributing to the growth of the probiotics segment across other applications.
Across the European Union, a rapidly aging population is becoming a key structural driver of dietary supplement demand, as a growing proportion of consumers are over 60 and increasingly focused on maintaining mobility, immunity, and overall quality of life. Age-related physiological changes, along with behavioral and social factors, raise vulnerability to chronic conditions such as osteoporosis, cardiovascular diseases, joint problems, and cognitive decline, prompting greater reliance on preventive nutrition. As a result, supplements such as calcium, vitamin D, omega-3s, magnesium, and targeted formulations for heart, bone, and brain health are becoming part of daily health routines rather than occasional purchases.
This trend is clearly reflected in Germany, where around one in five adults is aged 65 or older, and the share of seniors is expected to keep rising. According to figures from the Max Rubner Institute National Nutrition Survey II and the KPRA Age Study, women aged 65-80 are the most active supplement users, with 54% of women and 34% of men in this age group regularly taking food supplements. Such high adoption among older adults highlights how demographic ageing directly expands the core consumer base and supports sustained, long-term growth in the European dietary supplements market.
In August 2025, IBSA Group launched orodispersible film food supplements containing iron, vitamin D3, and vitamin B12 using its patented FilmTec technology across new European markets, expanding its international presence with easy-to-take, precisely dosed formats.
Europe Dietary Supplements Market Report Segmentation
This report forecasts revenue growth at the regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Europe dietary supplements market report based on ingredient, type, form, application, end user, distribution channel, product-form, form-end user, form-application, and region:Ingredients Outlook (Revenue, USD Billion, 2021-2033)
- Vitamins
- Multivitamin
- Vitamin A
- Vitamin B
- Vitamin C
- Vitamin D
- Vitamin K
- Vitamin E
- Botanicals
- Minerals
- Calcium
- Potassium
- Magnesium
- Iron
- Zinc
- Others
- Protein & Amino Acids
- Collagen
- Others
- Fibers & Specialty Carbohydrates
- Omega Fatty Acids
- Probiotics
- Prebiotics & Postbiotics
- Others
Type Outlook (Revenue, USD Billion, 2021-2033)
- OTC
- Prescribed
Form Outlook (Revenue, USD Billion, 2021-2033)
- Tablets
- Capsules
- Softgels
- Powder
- Gummies
- Liquid
- Others
Application Outlook (Revenue, USD Billion, 2021-2033)
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
End User Outlook (Revenue, USD Billion, 2021-2033)
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
Distribution Channel Outlook (Revenue, USD Billion, 2021-2033)
- Offline
- Hypermarkets/Supermarkets
- Pharmacies & Drug Stores
- Specialty Stores
- Practitioner
- Others
- Direct Sales (MLM)
- D2C
- Online
- Amazon
- Others
Product-Form Outlook (Revenue, USD Billion, 2021-2033)
- Vitamin
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Multivitamin
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin A
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin B
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin C
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin D
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin K
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin E
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Mineral
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Calcium
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Potassium
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Magnesium
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Iron
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Zinc
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Others (selenium, chromium, copper)
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Botanicals
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Protein & amino acids
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Collagen
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Others
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Fibers & Specialty Carbohydrates
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Omega Fatty Acids
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Probiotics
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Prebiotics & Postbiotics
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Others
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
Form-End User Outlook (Revenue, USD Billion, 2021-2033)
- Tablets
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
- Capsules
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
- Softgels
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
- Powders
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
- Gummies
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
- Liquid
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
- Others
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Geriatric
- Children
- Infants
Form-Application Outlook (Revenue, USD Billion, 2021-2033)
- Tablets
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Capsules
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Softgels
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Powders
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Gummies
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Liquid
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Others
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
Country Outlook (Revenue, USD Billion, 2021-2033)
- Europe
- Germany
- UK
- Spain
- Italy
- France
- Poland
- Russia
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Dietary Supplements Market Variables, Trends & Scope
Chapter 4. Consumer Behavior Analysis
Chapter 5. Europe Dietary Supplements Market: Ingredient Estimates & Trend Analysis
Chapter 6. Europe Dietary Supplements Market: Type Estimates & Trend Analysis
Chapter 7. Europe Dietary Supplements Market: Form Estimates & Trend Analysis
Chapter 8. Europe Dietary Supplements Market: Application Estimates & Trend Analysis
Chapter 9. Europe Dietary Supplements Market: End User Estimates & Trend Analysis
Chapter 10. Europe Dietary Supplements Market: Distribution Channel Estimates & Trend Analysis
Chapter 11. Europe Dietary Supplements Market: Product - Form Estimates & Trend Analysis
Chapter 12. Europe Dietary Supplements Market: Form - End User Estimates & Trend Analysis
Chapter 13. Europe Dietary Supplements Market: Form - Application Estimates & Trend Analysis
Chapter 14. Europe Dietary Supplements Market: Regional Estimates & Trend Analysis
Chapter 15. Competitive Analysis
List of Tables
List of Figures
Companies Mentioned
- Bayer AG
- Nestlé Health Science
- Reckitt Benckiser Group plc
- Sanofi
- GSK plc
- Holland & Barrett
- Glanbia plc
- Orkla Health
- Pharmavite LLC
- Bioglan
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | March 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 49.39 Billion |
| Forecasted Market Value ( USD | $ 97.76 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 10 |
